Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Kidney Disease Market Report 2024

Kidney Disease Global Market Report 2025 – By Treatment (Medication, Dialysis, Surgery, Other Treatments), By Indication (Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indication), By Route Of Administration (Oral, Parenteral), By End-User (Hospitals, Diagnostic Laboratories, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Kidney Disease Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Kidney Disease Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Kidney Disease Market Definition

Kidney diseases refer to a group of conditions that affect the function and structure of the kidneys. The kidneys are vital organs responsible for filtering waste and excess fluids from the blood, regulating electrolyte balance, and producing hormones that control blood pressure and red blood cell production.

The main types of treatments for kidney disease are medication, dialysis, surgery, and others. Medication refers to the use of drugs or pharmaceutical substances to treat, manage, or prevent various medical conditions, such as health problems related to kidney diseases. The treatments are indicated for acute kidney injury, chronic kidney disease, end-stage renal disease, and others through oral and parenteral routes of administration. These are used by various end-users such as hospitals, diagnostic laboratories, and others.

Kidney Disease Market Segmentation

The kidney disease market covered in this report is segmented –

1) By Treatment: Medication, Dialysis, Surgery, Other Treatments

2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indication

3) By Route Of Administration: Oral, Parenteral

4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Medication: Antihypertensives, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Vitamin D Analogs, immunosuppressants

2) By Dialysis: Hemodialysis, Peritoneal Dialysis

3) By Surgery: Kidney Transplant, Nephrectomy, Renal Artery Bypass, Ureteral Surgery

4) By Other Treatments: Lifestyle And Dietary Modifications, Renal Replacement Therapy, Palliative Care

Kidney Disease Market Size and growth rate 2025 to 2029: Graph

Kidney Disease Market Size 2025 And Growth Rate

The kidney disease market size has grown strongly in recent years. It will grow from $107.29 billion in 2024 to $114.74 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to rising chronic health conditions, aging population, genetic predisposition, medical research and education, environmental factors

Kidney Disease Market Growth Forecast

The kidney disease market size is expected to see strong growth in the next few years. It will grow to $149.44 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to global infectious disease management, precision medicine approaches, diabetes and obesity epidemic, healthcare policy changes, increased awareness and screening. Major trends in the forecast period include telemedicine for kidney care, focus on preventive nephrology, rise in home-based dialysis, regenerative therapies development, dietary modifications and nutrition.

Book your 30 minutes free consultation with our research experts

Contact Us

Kidney Disease Market Driver: Surging Incidence Of Kidney Diseases Fuels Growth In The Kidney Disease Market

The increased incidence of kidney diseases is expected to propel the growth of the kidney disease market going forward. Kidney diseases refer to a group of conditions that affect the function and structure of the kidneys. Kidney disorder medications are used to lower patients' blood pressure and reduce protein loss, slowing the progression of kidney damage, managing symptoms, and preventing complications. For instance, in June 2023, according to Kidney Research UK, a UK-based charitable organization that conducts research and advocacy efforts to improve understanding, prevention, and treatment of kidney diseases, an estimated 7.19 million people in the UK were affected by chronic kidney disease in 2023, representing more than 10% of the UK population and projected to increase to 7.61 million people by 2033. Therefore, the increased incidence of kidney diseases is driving the growth of the kidney disease market.

Kidney Disease Market Driver: High Blood Pressure And Diabetes As Catalysts For The Growth Of The Kidney Disease Market

The increasing prevalence of high blood pressure and diabetes is expected to propel the growth of the kidney disease market going forward. High blood pressure is a medical condition characterized by an elevated force of blood against the arterial walls, while diabetes is a metabolic disorder marked by high levels of blood glucose resulting from inadequate insulin production or utilization. High blood pressure and diabetes can lead to kidney diseases through the sustained damage they cause to the small blood vessels in the kidneys. Elevated blood pressure can strain the blood vessels, reducing their ability to effectively filter waste and excess fluids from the blood. Diabetes, especially when poorly controlled, can also contribute to kidney damage by affecting the small blood vessels and causing inflammation. For instance, in 2023, according to the National Diabetes Statistics Report by the Centers for Disease Control and Prevention, a US-based government agency, 38.4 million people in the United States will have diabetes, which is 11.6% of the population. Therefore, high blood pressure and diabetes are driving the growth of the kidney disease market.

Global Kidney Disease Market Major Players

Major companies operating in the kidney disease market include Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP, Abbott Laboratories, Fresenius SE & Co. KGaA, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Kyowa Kirin Co. Ltd., Cipla Inc., Endo International plc., Lupin Limited, Kissei Pharmaceutical Co. Ltd.

Global Kidney Disease Market Trend: The Rise Of AI Integration In Healthcare With Carenostics Leading The Way

Integration of AI-driven tools is a key trend gaining popularity in the kidney disease market. Companies operating in the kidney disease market are adopting new technologies to facilitate improved patient outcomes and sustain their position in the market. For instance, in November 2022, Carenostics, a US-based healthcare startup specializing in AI solutions, launched its inaugural product designed to analyze electronic health record (EHR) data for the early identification of chronic kidney disease (CKD). Carenostics seamlessly integrates AI-powered clinical decision support models into healthcare providers' electronic health record (EHR) systems. This integration empowers clinicians to accurately identify high-risk patients with chronic diseases, enabling them to take proactive measures for better patient outcomes.

Global Kidney Disease Market Trend: Strategic Partnerships Drive Innovation And Patient-Centric Care In The Kidney Disease Market

Major companies operating in the kidney disease market are adopting a strategic partnership approach to improve patient care, foster innovation, and accelerate the commercialization of therapies. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in June 2023, Southern California Kidney Consultants Inc., a US-based medical practices company, partnered with Strive Health, a US-based healthcare company. With this partnership, they aim to improve kidney disease treatment and care. The partnership includes 21 providers, based primarily in Orange County, who serve 5,000 patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).

Kidney Disease Market Merger And Acquisition: AstraZeneca Enhances Cardiorenal Capabilities Through Cincor Pharma Acquisition

In January 2023, AstraZeneca Pharmaceuticals LP, a US-based biopharmaceutical company, acquired CinCor Pharma Inc. for $1.8 billion. Through this acquisition, AstraZeneca intends to enhance its cardiorenal portfolio by incorporating CinCor's promising compound, baxdrostat (CIN-107). Baxdrostat is an aldosterone synthase inhibitor (ASI) specifically designed to lower blood pressure in patients with treatment-resistant hypertension, including those with chronic kidney disease. CinCor Pharma Inc. is a US-based clinical-stage biopharmaceutical company specializing in kidney disease medications and treatments.

Regional Outlook For The Global Kidney Disease Market

North America was the largest region in the kidney disease market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the kidney disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Kidney Disease Market?

The kidney disease market consists of revenues earned by providing services such as hemodialysis, peritoneal dialysis, and kidney transplantation. The market value includes the value of related goods sold by the service provider or included within the service offering. The kidney disease also includes sales of drugs like galafold, sibnayal, tarpeyo, and cystadrops. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Kidney Disease Industry?

The kidney disease research report is one of a series of new reports from The Business Research Company that provides kidney disease market statistics, including the kidney disease industry's global market size, regional shares, competitors with a kidney disease market share, detailed kidney disease market segments, market trends, and opportunities, and any further data you may need to thrive in the kidney disease industry. This kidney disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Kidney Disease Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $114.74 billion
Revenue Forecast In 2034 $149.44 billion
Growth Rate CAGR of 6.8% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Treatment: Medication, Dialysis, Surgery, Other Treatments
2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indication
3) By Route Of Administration: Oral, Parenteral
4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users Subsegments: 1) By Medication: Antihypertensives, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Vitamin D Analogs, Immunosuppressants
2) By Dialysis: Hemodialysis, Peritoneal Dialysis
3) By Surgery: Kidney Transplant, Nephrectomy, Renal Artery Bypass, Ureteral Surgery
4) By Other Treatments: Lifestyle And Dietary Modifications, Renal Replacement Therapy, Palliative Care
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP, Abbott Laboratories, Fresenius SE & Co. KGaA, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Kyowa Kirin Co. Ltd., Cipla Inc., Endo International plc., Lupin Limited, Kissei Pharmaceutical Co. Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Kidney Disease Market Characteristics

    3. Kidney Disease Market Trends And Strategies

    4. Kidney Disease Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

    5. Global Kidney Disease Growth Analysis And Strategic Analysis Framework

    5.1. Global Kidney Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Kidney Disease Market Growth Rate Analysis

    5.4. Global Kidney Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Kidney Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Kidney Disease Total Addressable Market (TAM)

    6. Kidney Disease Market Segmentation

    6.1. Global Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Medication

    Dialysis

    Surgery

    Other Treatments

    6.2. Global Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Acute Kidney Injury

    Chronic Kidney Disease

    End-Stage Renal Disease

    Other Indication

    6.3. Global Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oral

    Parenteral

    6.4. Global Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Diagnostic Laboratories

    Other End-Users

    6.5. Global Kidney Disease Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Antihypertensives

    Erythropoiesis-Stimulating Agents (ESAs)

    Phosphate Binders

    Vitamin D Analogs

    Immunosuppressants

    6.6. Global Kidney Disease Market, Sub-Segmentation Of Dialysis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hemodialysis

    Peritoneal Dialysis

    6.7. Global Kidney Disease Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Kidney Transplant

    Nephrectomy

    Renal Artery Bypass

    Ureteral Surgery

    6.8. Global Kidney Disease Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Lifestyle And Dietary Modifications

    Renal Replacement Therapy

    Palliative Care

    7. Kidney Disease Market Regional And Country Analysis

    7.1. Global Kidney Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Kidney Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Kidney Disease Market

    8.1. Asia-Pacific Kidney Disease Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Kidney Disease Market

    9.1. China Kidney Disease Market Overview

    9.2. China Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Kidney Disease Market

    10.1. India Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Kidney Disease Market

    11.1. Japan Kidney Disease Market Overview

    11.2. Japan Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Kidney Disease Market

    12.1. Australia Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Kidney Disease Market

    13.1. Indonesia Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Kidney Disease Market

    14.1. South Korea Kidney Disease Market Overview

    14.2. South Korea Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Kidney Disease Market

    15.1. Western Europe Kidney Disease Market Overview

    15.2. Western Europe Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Kidney Disease Market

    16.1. UK Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Kidney Disease Market

    17.1. Germany Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Kidney Disease Market

    18.1. France Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Kidney Disease Market

    19.1. Italy Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Kidney Disease Market

    20.1. Spain Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Kidney Disease Market

    21.1. Eastern Europe Kidney Disease Market Overview

    21.2. Eastern Europe Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Kidney Disease Market

    22.1. Russia Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Kidney Disease Market

    23.1. North America Kidney Disease Market Overview

    23.2. North America Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Kidney Disease Market

    24.1. USA Kidney Disease Market Overview

    24.2. USA Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Kidney Disease Market

    25.1. Canada Kidney Disease Market Overview

    25.2. Canada Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Kidney Disease Market

    26.1. South America Kidney Disease Market Overview

    26.2. South America Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Kidney Disease Market

    27.1. Brazil Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Kidney Disease Market

    28.1. Middle East Kidney Disease Market Overview

    28.2. Middle East Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Kidney Disease Market

    29.1. Africa Kidney Disease Market Overview

    29.2. Africa Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Kidney Disease Market Competitive Landscape And Company Profiles

    30.1. Kidney Disease Market Competitive Landscape

    30.2. Kidney Disease Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Johnson & Johnson Ltd. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. Kidney Disease Market Other Major And Innovative Companies

    31.1. Bayer AG

    31.2. Novartis AG

    31.3. Sanofi Aventis LLC

    31.4. Bristol-Myers Squibb Company

    31.5. AstraZeneca Pharmaceuticals LP

    31.6. Abbott Laboratories

    31.7. Fresenius SE & Co. KGaA

    31.8. GlaxoSmithKline Plc.

    31.9. Takeda Pharmaceutical Company Limited

    31.10. Eli Lilly and Co Ltd.

    31.11. Gilead Sciences Inc.

    31.12. Amgen Inc.

    31.13. Boehringer Ingelheim International GmbH

    31.14. Teva Pharmaceutical Industries Ltd.

    31.15. Astellas Pharma Inc.

    32. Global Kidney Disease Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Kidney Disease Market

    34. Recent Developments In The Kidney Disease Market

    35. Kidney Disease Market High Potential Countries, Segments and Strategies

    35.1 Kidney Disease Market In 2029 - Countries Offering Most New Opportunities

    35.2 Kidney Disease Market In 2029 - Segments Offering Most New Opportunities

    35.3 Kidney Disease Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Kidney Disease Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Kidney Disease Market, Sub-Segmentation Of Dialysis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Kidney Disease Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Kidney Disease Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Kidney Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Kidney Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Pfizer Inc. Financial Performance
  • Table 80: Johnson & Johnson Ltd. Financial Performance
  • Table 81: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 82: Merck & Co. Inc. Financial Performance
  • Table 83: AbbVie Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Kidney Disease Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Kidney Disease Market, Sub-Segmentation Of Dialysis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Kidney Disease Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Kidney Disease Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Kidney Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Kidney Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Kidney Disease Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Kidney Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Pfizer Inc. Financial Performance
  • Figure 80: Johnson & Johnson Ltd. Financial Performance
  • Figure 81: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 82: Merck & Co. Inc. Financial Performance
  • Figure 83: AbbVie Inc. Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

Read More

How Will The Nuclear Medicine Market Grow In 2022?

Read More

What Is The Pediatric Imaging Market Overview In 2022?

Read More

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Read More

Cancer biologics Global Market Report 2025 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications), By Distribution Channel (Hospitals, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Diagnostics Global Market Report 2025 – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications), By End-User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Tumor Ablation Therapy Devices Global Market Report 2025 – By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies), By Treatment (Surgical, Laparoscopic, Percutaneous), By Application (Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications), By End User (Hospitals, Oncology Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Tumor Embolization Devices Global Market Report 2025 – By Type (Radioembolic Agents, Non-radioactive Embolic Agents), By Application (Cancer Tumors, Noncancerous Tumors), By End User (Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Monoclonal Antibodies Global Market Report 2025 – By Monoclonal Antibody Therapies (Avastin, Herceptin, Keytruda, Opdivo, Darzalex, Perjeta, Others), By Application (Breast Cancer, Blood Cancer, Lung Cancer, Brain Tumor, Colorectal Cancer, Cervical Cancer, Gastric Cancer, Others), By End-User (Hospitals, Research Laboratories, Others) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Vaccines Global Market Report 2025 – By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), By Cancer Type (Prostate, Cervical, Colorectal, Throat, Other Cancer Types), By End-User (Cancer Treatment Centers, Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Clinical Decision Tools Global Market Report 2025 – By Type (Risk Assessment Tool (RAT), Qcancer), By End-User (Hospital, Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Immunotherapy Global Market Report 2025 – By Product (Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy), By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Multiple Myeloma), By End User (Hospitals, Cancer Research Centers, Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Kidney Disease market?

Kidney diseases refer to a group of conditions that affect the function and structure of the kidneys. The kidneys are vital organs responsible for filtering waste and excess fluids from the blood, regulating electrolyte balance, and producing hormones that control blood pressure and red blood cell production. For further insights on the Kidney Disease market, request a sample here

How will the Kidney Disease market drivers and restraints affect the market dynamics? What forces will shape the Kidney Disease industry going forward?

The Kidney Disease market major growth driver - Surging Incidence Of Kidney Diseases Fuels Growth In The Kidney Disease Market. For further insights on the Kidney Disease market, request a sample here

What is the forecast market size or the forecast market value of the Kidney Disease market?

The Kidney Disease market size has grown strongly in recent years. The kidney disease market size has grown strongly in recent years. It will grow from $107.29 billion in 2024 to $114.74 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to rising chronic health conditions, aging population, genetic predisposition, medical research and education, environmental factors The kidney disease market size is expected to see strong growth in the next few years. It will grow to $149.44 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to global infectious disease management, precision medicine approaches, diabetes and obesity epidemic, healthcare policy changes, increased awareness and screening. Major trends in the forecast period include telemedicine for kidney care, focus on preventive nephrology, rise in home-based dialysis, regenerative therapies development, dietary modifications and nutrition. For further insights on the Kidney Disease market, request a sample here

How is the Kidney Disease market segmented?

The kidney disease market covered in this report is segmented –
1) By Treatment: Medication, Dialysis, Surgery, Other Treatments
2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indication
3) By Route Of Administration: Oral, Parenteral
4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users Subsegments:
1) By Medication: Antihypertensives, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Vitamin D Analogs, Immunosuppressants
2) By Dialysis: Hemodialysis, Peritoneal Dialysis
3) By Surgery: Kidney Transplant, Nephrectomy, Renal Artery Bypass, Ureteral Surgery
4) By Other Treatments: Lifestyle And Dietary Modifications, Renal Replacement Therapy, Palliative Care For further insights on the Kidney Disease market, request a sample here

Which region has the largest share of the Kidney Disease market? What are the other regions covered in the report?

North America was the largest region in the kidney disease market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Kidney Disease market, request a sample here.

Who are the major players in the Kidney Disease market?

Major companies operating in the kidney disease market include Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP, Abbott Laboratories, Fresenius SE & Co. KGaA, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Kyowa Kirin Co. Ltd., Cipla Inc., Endo International plc., Lupin Limited, Kissei Pharmaceutical Co. Ltd. . For further insights on the Kidney Disease market, request a sample here.

What are the key trends in the Kidney Disease market?

Major trends in the Kidney Disease market include The Rise Of AI Integration In Healthcare With Carenostics Leading The Way. For further insights on the Kidney Disease market, request a sample here.

What are the major opportunities in the Kidney Disease market? What are the strategies for the Kidney Disease market?

For detailed insights on the major opportunities and strategies in the Kidney Disease market, request a sample here.

How does the Kidney Disease market relate to the overall economy and other similar markets?

For detailed insights on Kidney Disease's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Kidney Disease industry?

For detailed insights on the mergers and acquisitions in the Kidney Disease industry, request a sample here.

What are the key dynamics influencing the Kidney Disease market growth? SWOT analysis of the Kidney Disease market.

For detailed insights on the key dynamics influencing the Kidney Disease market growth and SWOT analysis of the Kidney Disease industry, request a sample here.